Physician profile

Christopher H Lee

Diagnostic Radiology · Orange, CA

NPI 1528380011

$751.22

in general payments reported to CMS, 2019-2025

9 companies · $13.48 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$98.68

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Angiodynamics, INC. $194.10 2019
Siemens Medical Solutions USA, INC. $170.09 2019
Ethicon US, LLC $118.12 2021
Stryker Corporation $99.20 2022
Depuy Synthes Sales INC. $53.60 2024 Na
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $43.78 2021
Depuy Synthes Products, INC. $31.60 2024 Inhance
Merz North America, INC. $27.25 2019
Cook Medical LLC $13.48 2025 Cook

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher H Lee

$751.22

in general payments reported 2019-2025

Years
2019-2025
Top company
Angiodynamics, INC.

https://glasscript.com/doctor/378079/christopher-h-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.